Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
23.82 USD | -4.68% | -0.75% | +212.19% |
Apr. 08 | Canaccord Genuity Adjusts Price Target on CervoMed to $65 From $50, Maintains Buy Rating | MT |
Mar. 29 | CervoMed Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | 8.4M | Sales 2025 * | 6.5M | Capitalization | 197M |
---|---|---|---|---|---|
Net income 2024 * | -12M | Net income 2025 * | -26M | EV / Sales 2024 * | 18 x |
Net cash position 2024 * | 45.3M | Net cash position 2025 * | 113M | EV / Sales 2025 * | 12.9 x |
P/E ratio 2024 * |
-17.4
x | P/E ratio 2025 * |
-10.8
x | Employees | 8 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.86% |
1 day | -4.68% | ||
1 week | -0.75% | ||
Current month | +2.23% | ||
1 month | +21.41% | ||
3 months | +157.79% | ||
6 months | +180.90% | ||
Current year | +212.19% |
Managers | Title | Age | Since |
---|---|---|---|
John Alam
CEO | Chief Executive Officer | 62 | 23-08-15 |
William Tanner
DFI | Director of Finance/CFO | 66 | 23-08-15 |
Kelly Blackburn
CTO | Chief Tech/Sci/R&D Officer | 60 | 23-08-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Joshua Boger
CHM | Chairman | 72 | Feb. 06 |
John Alam
CEO | Chief Executive Officer | 62 | 23-08-15 |
Frank Zavrl
BRD | Director/Board Member | 58 | 23-08-15 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 23.82 | -4.68% | 31,022 |
24-04-25 | 24.99 | +1.59% | 26,007 |
24-04-24 | 24.6 | +1.28% | 30,121 |
24-04-23 | 24.29 | +1.67% | 15,734 |
24-04-22 | 23.89 | -0.46% | 35,003 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+212.19% | 197M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- CRVO Stock